Q3 2024 Earnings Call Transcript February 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for ...

Stephanie Lee Griffin; Chief Operating Officer; Roivant Sciences Ltd. Matt Gline; Chief Executive Officer, Director; Roivant Sciences Ltd. Dave Risinger; Analyst; Le ...

Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my ...

Stunning discoveries and fresh breakthroughs in DNA analysis are changing our understanding of our own evolution and offering a new picture of the "other humans" that our ancestors met across ...

Q3 2025 Earnings Call Transcript February 10, 2025 Columbus McKinnon Corporation misses on earnings expectations. Reported ...

Q4 2024 Earnings Conference Call February 11, 2025 8:00 AM ETCompany ParticipantsCraig Marshall - Investor RelationsMurray Auchincloss ...

Key highlights Proposed dividend The Board of Directors will propose a dividend ofEUR 0.25(EUR 0.20)per share at the Annual General Meeting on20 March 2025. The Board of Directors proposes that the ...